Debate on long-acting β agonists for asthma: they think it's all over

Lancet Respir Med. 2017 Mar;5(3):e14-e15. doi: 10.1016/S2213-2600(17)30053-X.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-Agonists / therapeutic use*
  • Asthma / drug therapy*
  • Bronchodilator Agents / therapeutic use
  • Budesonide, Formoterol Fumarate Drug Combination / therapeutic use*
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Fluticasone-Salmeterol Drug Combination / therapeutic use*
  • Glucocorticoids / therapeutic use*
  • Humans
  • Nebulizers and Vaporizers
  • Treatment Outcome

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Budesonide, Formoterol Fumarate Drug Combination
  • Delayed-Action Preparations
  • Fluticasone-Salmeterol Drug Combination
  • Glucocorticoids